Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (211-220 of 391) with videos related to

Pageof 40
Sort By:
Neuron|March 24, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
Neuron|May 18, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Nature Medicine|March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Nature Aging|March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker modelGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
JAMA Neurology|July 28, 2024
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMeng Jiang, Nelly Joseph-Mathurin, Yong Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMeng Jiang, Nelly Joseph-Mathurin, Yong Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's diseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Pageof 40

Showing results (211-220 of 391) with videos related to

Sort By:
Pageof 40
Neuron|March 24, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
Neuron|May 18, 2018
Tau Kinetics in Neurons and the Human Central Nervous SystemChihiro Sato, Nicolas R Barthélemy, Kwasi G Mawuenyega, et al.
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Nature Medicine|March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
Nature Aging|March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker modelGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
JAMA Neurology|July 28, 2024
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMeng Jiang, Nelly Joseph-Mathurin, Yong Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMeng Jiang, Nelly Joseph-Mathurin, Yong Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's diseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Pageof 40